BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 24222137)

  • 1. The E3 ubiquitin ligase SIAH2 is a prosurvival factor overexpressed in oral cancer.
    Hsieh SC; Kuo SN; Zheng YH; Tsai MH; Lin YS; Lin JH
    Anticancer Res; 2013 Nov; 33(11):4965-73. PubMed ID: 24222137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of WWP1 promotes tumorigenesis and predicts unfavorable prognosis in patients with hepatocellular carcinoma.
    Zhang XF; Chao J; Pan QZ; Pan K; Weng DS; Wang QJ; Zhao JJ; He J; Liu Q; Jiang SS; Chen CL; Zhang HX; Xia JC
    Oncotarget; 2015 Dec; 6(38):40920-33. PubMed ID: 26506518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of SIAH2, an ubiquitin E3 ligase, is associated with resistance to endocrine therapy in breast cancer.
    Jansen MP; Ruigrok-Ritstier K; Dorssers LC; van Staveren IL; Look MP; Meijer-van Gelder ME; Sieuwerts AM; Helleman J; Sleijfer S; Klijn JG; Foekens JA; Berns EM
    Breast Cancer Res Treat; 2009 Jul; 116(2):263-71. PubMed ID: 18629630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Expression of the Ubiquitin Ligase SIAH2 (Seven In Absentia Homolog 2) Is Increased in Human Lung Cancer.
    Moreno P; Lara-Chica M; Soler-Torronteras R; Caro T; Medina M; Álvarez A; Salvatierra Á; Muñoz E; Calzado MA
    PLoS One; 2015; 10(11):e0143376. PubMed ID: 26580787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The expression and function of E3 ligase SIAH2 in acute T lymphoblastic leukemia.
    Chen H; Wang N; Yang G; Guo Y; Shen Y; Wang X; Zhang P; Xu Y
    Leuk Res; 2016 Mar; 42():28-36. PubMed ID: 26859780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ALY as a potential contributor to metastasis in human oral squamous cell carcinoma.
    Saito Y; Kasamatsu A; Yamamoto A; Shimizu T; Yokoe H; Sakamoto Y; Ogawara K; Shiiba M; Tanzawa H; Uzawa K
    J Cancer Res Clin Oncol; 2013 Apr; 139(4):585-94. PubMed ID: 23242234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CMTM3 inhibits cell growth and migration and predicts favorable survival in oral squamous cell carcinoma.
    Zhang H; Zhang J; Nan X; Li X; Qu J; Hong Y; Sun L; Chen Y; Li T
    Tumour Biol; 2015 Sep; 36(10):7849-58. PubMed ID: 25946973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance.
    Su L; Wang Y; Xiao M; Lin Y; Yu L
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):484-91. PubMed ID: 20868995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of Siah2 Is Associated With Poor Prognosis in Patients With Epithelial Ovarian Carcinoma.
    Gao Y; Liu Y; Meng F; Shang P; Wang S; Zhang Y; Sun Y; Wang Y; Wang J; Chen X
    Int J Gynecol Cancer; 2016 Jan; 26(1):114-9. PubMed ID: 26512788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant promoter hypermethylation of the CHFR gene in oral squamous cell carcinomas.
    Baba S; Hara A; Kato K; Long NK; Hatano Y; Kimura M; Okano Y; Yamada Y; Shibata T
    Oncol Rep; 2009 Nov; 22(5):1173-9. PubMed ID: 19787237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression pattern of DKK3, dickkopf WNT signaling pathway inhibitor 3, in the malignant progression of oral submucous fibrosis.
    Zhou S; Zhu Y; Mashrah M; Zhang X; He Z; Yao Z; Zhang C; Guo F; Hu Y; Zhang C
    Oncol Rep; 2017 Feb; 37(2):979-985. PubMed ID: 27959428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. WWP1 gene is a potential molecular target of human oral cancer.
    Lin JH; Hsieh SC; Chen JN; Tsai MH; Chang CC
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Aug; 116(2):221-31. PubMed ID: 23849376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knockdown of IFI27 inhibits cell proliferation and invasion in oral squamous cell carcinoma.
    Wang H; Qiu X; Lin S; Chen X; Wang T; Liao T
    World J Surg Oncol; 2018 Mar; 16(1):64. PubMed ID: 29580248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversion-inducing cysteine-rich protein with Kazal motifs and its regulation by glycogen synthase kinase 3 signaling in oral cancer.
    Pramanik KK; Singh AK; Alam M; Kashyap T; Mishra P; Panda AK; Dey RK; Rana A; Nagini S; Mishra R
    Tumour Biol; 2016 Nov; 37(11):15253-15264. PubMed ID: 27696293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-stromal crosstalk in invasion of oral squamous cell carcinoma: a pivotal role of CCL7.
    Jung DW; Che ZM; Kim J; Kim K; Kim KY; Williams D; Kim J
    Int J Cancer; 2010 Jul; 127(2):332-44. PubMed ID: 19937793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. UBE2S associated with OSCC proliferation by promotion of P21 degradation via the ubiquitin-proteasome system.
    Yoshimura S; Kasamatsu A; Nakashima D; Iyoda M; Kasama H; Saito T; Takahara T; Endo-Sakamoto Y; Shiiba M; Tanzawa H; Uzawa K
    Biochem Biophys Res Commun; 2017 Apr; 485(4):820-825. PubMed ID: 28257844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcription factor HBP1 is a direct anti-cancer target of transcription factor FOXO1 in invasive oral cancer.
    Chan CY; Huang SY; Sheu JJ; Roth MM; Chou IT; Lien CH; Lee MF; Huang CY
    Oncotarget; 2017 Feb; 8(9):14537-14548. PubMed ID: 28099936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of survivin and p53 in human oral cancer: correlation with clinicopathologic findings.
    Khan Z; Tiwari RP; Mulherkar R; Sah NK; Prasad GB; Shrivastava BR; Bisen PS
    Head Neck; 2009 Aug; 31(8):1039-48. PubMed ID: 19340865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Keratin 17 Is Induced in Oral Cancer and Facilitates Tumor Growth.
    Khanom R; Nguyen CT; Kayamori K; Zhao X; Morita K; Miki Y; Katsube K; Yamaguchi A; Sakamoto K
    PLoS One; 2016; 11(8):e0161163. PubMed ID: 27512993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Receptor tyrosine kinase, RON, promotes tumor progression by regulating EMT and the MAPK signaling pathway in human oral squamous cell carcinoma.
    Kim SA; Lee KH; Lee DH; Lee JK; Lim SC; Joo YE; Chung IJ; Noh MG; Yoon TM
    Int J Oncol; 2019 Aug; 55(2):513-526. PubMed ID: 31268163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.